RNA
Atrium Therapeutics, Inc.
8.30$
-1.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.1% | +26.4% | -97.1% | +511.9% | +192.7% | +37.4% | -1.1% | +3.6% | +14.0% | +70.9% | |
| – | -10.0% | +42.9% | -74.0% | +72.3% | +158.6% | -98.3% | +117.1% | +51.5% | +32.1% | +49.5% | |
| – | – | – | – | – | +192.7% | +37.4% | -1.1% | -19.1% | +46.1% | +70.9% | |
| – | -4.7% | +34.0% | -66.8% | +72.3% | +158.6% | +169.1% | +48.6% | +27.0% | +59.0% | -82.3% | |
| – | – | – | – | +109.4% | +163.3% | +94.6% | +44.0% | +43.6% | +59.1% | -51.7% | |
| – | – | – | – | +80.7% | +159.9% | +149.4% | +47.7% | +29.2% | +60.4% | -75.5% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +928.8% | -97.2% | +205.7% | +790.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +928.8% | -105.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.